News | September 28, 2024
Baxter launches nextgen airway clearance system
Developed in consultation with clinicians and patients for an enhanced user experience
Developed in consultation with clinicians and patients for an enhanced user experience
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
He specializes in financial planning, audit, compliance and ERP implementation, with extensive experience in leading automation and risk management projects
ForDoz Pharma Corporation, USA (ForDoz) received an approval for its ANDA from the USFDA
Doxorubicin Hydrochloride Liposome Injection (RLD Doxil) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT May 2024)
The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind
Subscribe To Our Newsletter & Stay Updated
